Mosanna Therapeutics secures $80m in funding
Mosanna Therapeutics has secured $80m in a Sequence A funding spherical to advance a brand new nighttime nasal spray for obstructive sleep apnoea (OSA).
The corporate is growing MOS118, an easy-to-use nasal spray for OSA that helps restore the physique’s pure airway management.
Pivotal bioVenture Companions and EQT Life Sciences headed the financing. Co-lead buyers had been Forbion, Broadview Ventures and Norwest.
Returning buyers for this spherical had been Supermoon Capital and Excessive-Tech Gründerfonds (HTGF), and founding investor Forty51 Ventures.
EQT Life Sciences managing director Daniela Begolo said: “What units Mosanna aside is its basically completely different strategy to sleep apnea, treating it as a neurological and muscular dysfunction moderately than a purely mechanical challenge.
“MOS118 is the primary remedy with the potential to revive the physique’s pure airway reflex with the simplicity of a nasal spray. MOS118 has the potential to dramatically enhance adherence and outcomes in a affected person inhabitants that has lengthy been underserved.”
OSA impacts round one billion people worldwide and is related to important well being dangers similar to hypertension and heart problems.
Present remedies typically contain mechanical options that may be uncomfortable for sufferers.
Mosanna’s MOS118 nasal spray goals to deal with these points by concentrating on higher airway muscular tissues to keep up airway patency throughout sleep.
The brand new funding will help the spray via its Part II growth whereas additionally increasing Mosanna’s product pipeline.
Mosanna has appointed Dr David Weber as president and CEO to information the following stage of the corporate’s development.
Pivotal bioVenture companion Jeni Lee said: “Along with his deep experience in biotech innovation and patient-centric therapies, Dr Weber was the perfect selection to guide Mosanna into the following chapter.
“We sit up for partnering with him and the Mosanna crew to ship on the promise of this life-changing sleep apnoea remedy.”